Alternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column #
|
|
- Alice Rhoda O’Connor’
- 5 years ago
- Views:
Transcription
1 RESERVED RESERVED RESERVED RESERVED RESERVED RESERVED RESERVED
2 RX HOSP--SCOPE REG COC Describes the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at the reporting facility. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Scope of Regional Lymph Node Surgery at the reporting facility for all cases diagnosed before January 1, In evaluating quality of care and treatment practices it is important to identify the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event. referral patterns and treatment by type of hospital. Knowing the extent of treatment given at a particular hospital also helps resolve coding issues. Codes: 314A
3 RX HOSP--SURG OTH COC Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site at this facility. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Surgery Other Regional/Distant Sites at the reporting facility for all cases diagnosed before January 1, The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. If central registries wish to study the treatment given at particular hospitals, the hospital-level treatment fields must be used. The summary treatment fields, conversely, combine information across all hospitals that provide first course of treatment for the tumor. Hospitalspecific fields allow studies of detailed referral patterns and treatment by type of hospital. Knowing what part of the treatment was given at a particular hospital also helps resolve coding issues. Codes 318A
4 RX HOSP--SURG SITE COC Describes surgical procedures used to treat the primary site of the reportable tumor. This item records that portion of the first course of treatment given at the reporting facility. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Surgery Primary Site at the reporting facility for all cases diagnosed before January 1, See Chapter V, Unresolved Issues, for a discussion of differences in treatment coding among groups and over time. referral patterns and treatment by type of hospital. Knowing what part of the treatment was given at a particular hospital also helps resolve coding issues. Codes (in addition to the site-specific codes) 00 No cancer-directed surgery performed. 99 Unknown if cancer-directed surgery performed. 319A
5 RX SUMM--SCOPE REG SEER/COC Describes the removal, biopsy or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at all facilities. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Scope of Regional Lymph Node Surgery at all facilities for all cases diagnosed before January 1, In evaluating quality of care and treatment practices it is important to identify the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event. referral patterns and treatment by type of hospital. Knowing the extent of treatment given at a particular hospital also helps resolve coding issues. Codes 331A
6 RX SUMM--SURG OTH SEER/COC Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site given at all facilities as part of the first course of treatment. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Surgery Regional/Distant Sites at all facilities for all cases diagnosed before January 1, The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. If central registries wish to study the treatment given at particular hospitals, the hospital-level treatment fields must be used. The summary treatment fields, conversely, combine information across all hospitals that provide first course of treatment for the tumor. Hospitalspecific fields allow studies of detailed referral patterns and treatment by type of hospital. Knowing what part of the treatment was given at a particular hospital also helps resolve coding issues. Codes 334A
7 RX SUMM--SURG SITE SEER/COC Site-specific codes for the type of surgery to the primary site performed as part of the first course of treatment. This includes treatment given at all facilities as part of the first course of treatment. This field is to be used for ROADS codes after the ROADS to FORDS conversion. It is also to be used to code Surgery Primary Site at all facilities for all cases diagnosed before January 1, referral patterns and treatment by type of hospital. Knowing what part of the treatment was given at a particular hospital also helps resolve coding issues. Codes (in addition to the site-specific codes) 00 No primary site surgery performed. 99 Unknown if primary site surgery performed. 334B
ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry
ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data Item Name Data Item Number NPCR Collect Recommendation
More informationStandards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit
10 Record Type R R NAACCR 20 Patient ID Number R R R Reporting Registry 30 Registry Type NAACCR 35 FIN Coding System S NAACCR 37 Reserved 00 40 Registry ID S R R NAACCR 50 NAACCR Record Version R R NAACCR
More information1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
More information1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
More informationAPPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13) New Required Item by ASCR R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data NPCR Collect
More information2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010
2010 Cancer Data Collection Updates: Standards Volume II, Version 12 NAACCR 2009 2010 Webinar Series Introduction What s New for 2010 Record length and record layout New/changed data items Multiple Primary
More informationChanges to SEER Data Set for Scope of Regional Lymph Node Surgery
Changes to SEER Data Set for 2003 Scope of Regional Lymph Node Surgery Effective 1/1/2003. All primary sites will have the same coding structure for this field None No regional lymph node surgery. No lymph
More informationNAACR Treatment Webinar Quiz 1
NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.
More informationRequirements for Abstracted Text
Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation
More informationPathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative
GATRA 2016 Breast Case Demographics Name: Autumn Leaf Sex: F Date of Birth: 3/26/75 SSN: 098765432 Race: African American Marital Status: Single Address: 3615 Burnt Hickory Trail, Helen, GA 37285, White
More informationAJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer
More informationNAACCR Webinar Series 1
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar
More informationKIDNEY MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) KIDE MEASURE SPECIFICATIOS Introduction The Commission on Cancer s (CoC) ational Cancer Data Base (CDB) staff has undertaken an effort to improve the transparency
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
More informationCancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
MEASURE SPECIFICATIOS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) ational Cancer Data Base (CDB) staff has undertaken
More informationObtaining the diagnosis:
CANCER SURGERY Obtaining the diagnosis: Most cancers are first biopsied in order to determine tumor type. Incisional biopsies extract small portions of tumor for microscopic examination. Excisional biopsies
More informationThe Components of an Abstract. Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018
The Components of an Abstract Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018 1 Abstracts Should Tell A Story 2 The Components of an Abstract Who
More informationNCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions
NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without
More informationI.2 CNExT This section was software specific and deleted in 2008.
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION
More informationGASTRIC MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) GASTRIC MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast
Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationAbstracting and Coding Boot Camp: Cancer Case Scenarios
NAACC R 2015-2016 Webinar Series Abstracting and Coding Boot Camp: Cancer Case Scenarios NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org
More information2015 Public Outcomes Report Cancer Program Practice Profile Reports 2013 Breast and Colon Cancer
As a Commission on Cancer (CoC)-accredited cancer program, HealthEast ensures that patients with cancer are treated according to nationally accepted measures. Measures for Quality of Cancer Care Each year,
More informationThe Commission on Cancer: Reengineering the National Cancer Data Base
The Commission on Cancer: Reengineering the National Cancer Data Base Stephen B. Edge MD FACS Chair Commission on Cancer American College of Surgeons Alfiero Chair of Breast Oncology Professor of Surgery
More informationNAPBC Standards. Continuum of Care for Breast Abnormalities. NAPBC Standards Manual. Cindy Burgin #70
#70 NAPBC Standards Cindy Burgin March 18, 2014 I have no financial conflicts of interest, but wish I did! Copyright NAPBC 2014 Content cannot be reproduced or repurposed without written permission of
More information5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry
AJCC Stage Introduction and General Rules Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More information11/3/2016. Outcomes Watching It Grow. What will we discuss? GATRA Annual Conference 2016 Lisa Connor, CTR
Outcomes Watching It Grow GATRA Annual Conference 2016 Lisa Connor, CTR The abstract begins after case finding The abstract is in progress The abstract is complete The abstract is revisited and nurtured
More informationGeneral Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators
American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.
More informationInteractive Discussion of Part I CS Coding Instructions: Working the Cases
Interactive Discussion of Part I CS Coding Instructions: Working the Cases April Fritz, RHIT, CTR Donna M. Gress, RHIT, CTR Jennifer Ruhl, RHIT, CCS, CTR This presentation was supported by the Cooperative
More information7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+
2014 Grade Coding Instructions ICD-O-3 Updates 1 I M P L E M E N T A T I O N T I M E L I N E ( S ) 2 0 1 4 F C D S D A M A P P E N D I X H A N D O U T S F C D S A N N U A L C O N F E R E N C E O R L A
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationPractice Analysis and Content Specifications. for Registered Radiologist Assistant
Practice Analysis and Content Specifications for Registered Radiologist Assistant Final Report For New Documents Implemented July 2018 The American Registry of Radiologic Technologists 1255 Northland Drive
More informationMammary Tumors. by Pamela A. Davol
Mammary Tumors by Pamela A. Davol Malignant tumors of the mammary glands occur with a higher incident than any other form of cancer in female dogs. Additionally, evidence suggests that females with benign
More informationPrognosis for stage 4 lung cancer
P ford residence southampton, ny Prognosis for stage 4 lung cancer Dec 18, 2017. Survival rates tell you what portion of people with the same type and stage of cancer are still alive a certain amount of
More information3/23/2017. Disclaimer. Common Changes in TNM Staging. Overview. Overview. Understanding Terminology. Overview
Common Changes in TNM Staging Understanding the General Rules of Cancer Staging Thomas P. Baker, MD FCAP March 5, 2017 Disclaimer The identification of specific products or scientific instrumentation is
More informationEXPLORING THE INTERNAL CONSISTENCY OF REGISTRY DATA ON STAGE OF DISEASE AT DIAGNOSIS
EXPLORING THE INTERNAL CONSISTENCY OF REGISTRY DATA ON STAGE OF DISEASE AT DIAGNOSIS Richard Porter Catherine N. Correa John P. Fulton Holly L. Howe Chris Newton Judy Nowak Steven D. Roffers This paper
More informationFORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute
FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute Charlotte, NC National Accreditation Program for Breast
More informationThe New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards
More informationACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More information14. Mucosal Melanoma of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More information10. HPV-Mediated (p16+) Oropharyngeal Cancer
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationOVARY MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) OVARY MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve the
More informationVISUAL EDITING GUIDELINES March 2015 (revised June 2015)
March 2015 (revised June 2015) Developed for The Cancer Registry of Greater California under the direction of Winny Roshala, BA, CTR, Data Quality Control Director By the following contributing Authors:
More information6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationFCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data
FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data 2011 FCDS Educational Webcast Series Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR August 18, 2011 CDC-NPCR
More informationRitu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL
Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL email: r-nayar@northwestern.edu Nothing to disclose College of American Pathologists
More informationNICE diagnostics guidance on intraoperative tests (RD 100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer
NICE diagnostics guidance on intraoperative tests (RD 100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer NICE provided the content for this booklet which is
More informationequally be selected on the basis of RE status of the primary tumour. These initial studies measured RE
Br. J. Cancer (1981) 43, 67 SOLUBLE AND NUCLEAR OESTROGEN RECEPTOR STATUS IN HUMAN BREAST CANCER IN RELATION TO PROGNOSIS R. E. LEAKE*, L. LAING*, C. McARDLEt AND D. C. SMITH$ From the *Department of Biochemistry,
More information46. Merkel Cell Carcinoma
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationExercise 15: CSv2 Data Item Coding Instructions ANSWERS
Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report
More informationLesson 8 Classifications
Lesson 8 Classifications Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease
More informationQUICK-START GUIDE NCDB Participant Use File (NCDB PUF)
QUICK-START GUIDE 2015 NCDB Participant Use File (NCDB PUF) The data included in this zipped file are provided in a flat text file format, and should be read with software such as SAS, SPSS (PASW), STATA,
More informationOutline. How to Use the AJCC Cancer Staging Manual, 7 th ed. 7/9/2015 FCDS ANNUAL CONFERENCE ST PETERSBURG, FLORIDA JULY 30, 2015.
1 How to Use the AJCC Cancer Staging Manual, 7 th ed. FCDS ANNUAL CONFERENCE ST PETERSBURG, FLORIDA JULY 30, 2015 Steven Peace, CTR Outline 2 History, Purpose and Background Purchase and Ordering Information
More informationCancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff
More informationWe re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015
VOLUME 19 ISSUE 1 January 2015 We re on the Web! Visit us at www.kumc.edu/kcr January is National Cervical Cancer Screening Month. Cervical cancer begins in the lining of the cervix (organ connecting the
More informationTOPIC Presenter Rihab Sidahmed Ibnoaf Arabic perspective of principles of Screening and diagnostics in Ovarian Cancer, Sudan.
Arabic perspective of principles of Screening and diagnostics in Ovarian Cancer, Sudan. Ovarian cancer is the seventh most common cancer, and it is the most common cause of mortality from gynecological
More informationDIAL-IN INFORMATION FOR ALL THE TELECONFERENCES: Dial In Number: Participant Code:
FCDS DAM 2006 SUPPLEMENT A HEMATOLOGIC MALIGNANCIES SOUTH FLORIDA NBC 6 VIDEO REPORT ON WOMEN AND CANCER (Includes comments from FCDS's Deputy Project Director, Dr. Jill MacKinnon) FCDS REGISTER VOL. 33
More informationLeveraging Your Cancer Registry: A Strategy for Survey Success
CoC-trained consultants on staff Leveraging Your Cancer Registry: A Strategy for Survey Success Toni Hare, RHIT, CTR CoC-trained Consultant Vice President, CHAMPS Oncology November 27, 2012 Georgia s Best
More informationAbstract Code Manual
16th Edition Abstract Code Manual MISSOURI CANCER REGISTRY AND RESEARCH CENTER University of Missouri Columbia 2016 Revised Missouri Cancer Registry and Research Center Abstract Code Manual 16th Edition
More informationStandards Deficiency Resolution
Standards Deficiency Resolution If a deficiency or deficiencies are identified during the survey process, the center has 12 months from the date of survey to complete the deficiency resolution process.
More informationUsing Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer
Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer Dr Gill Lawrence, WM KIT, on behalf of Breast SSCRG Cancer Outcomes Conference, Brighton, June 2013
More information4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines
SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific
More informationGREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE
GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE CANCER REGISTRY REPORT The Cancer Data Management System/Cancer Registry collects data on all types of cancer diagnosed or treated
More informationThursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209
KCR newsletter March 2018 KCR 2018 Fall Workshop/Regional Meeting 2018 Tri-State Regional Cancer Registrars Meeting Presented by: Kentucky Cancer Registry, Indiana Cancer Consortium, and Ohio Cancer Incidence
More informationJoint ASPS & ASAPS Statement on Breast Implant Associated ALCL
Joint ASPS & ASAPS Statement on Breast Implant Associated ALCL The American Society of Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS) are committed to patient safety,
More informationNPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
More informationWhat s New in 2012 FCDS Annual Meeting Review
What s New in 2012 FCDS Annual Meeting Review FCDS Educational Webcast Series August 16, 2012 FCDS Staff Steven Peace, CTR 2012 FORDS Cancer Program Standards CSv02.04 1 What is Cancer / What is Reportable
More informationEvaluation of Abstracting: Cancers Diagnosed in MCSS Quality Control Report 2005:2. Elaine N. Collins, M.A., R.H.I.A., C.T.R
Evaluation of Abstracting: Cancers Diagnosed in 2001 MCSS Quality Control Report 2005:2 Elaine N. Collins, M.A., R.H.I.A., C.T.R Jane E. Braun, M.S., C.T.R John Soler, M.P.H September 2005 Minnesota Department
More informationRegistrar s Guide to Chapter 1, AJCC Seventh Edition. Overview. Learning Objectives. Describe intent and purpose of AJCC staging
Registrar s Guide to Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease Control
More information2016 Uterine Cancer Annual Report
2016 Uterine Cancer Annual Report Overview At Carolinas HealthCare System s Levine Cancer Institute, we offer comprehensive care focused on using the latest technology and innovative techniques in the
More information47. Melanoma of the Skin
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More information10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards,
2 013-2014 QUALITY IMPROVEMENT EDUCATION AND TRAINING NCRA CEU # 2013-114 Continuing Education Hours Date Event Sponsor 7/25/2013-7/26/2013 CEU Hrs FCDS Annual Conference, Sunrise, FL FCDS 8.25 2013-115
More information2018 Coding Manuals: SEER and STORE 2018 KCR 2018 SPRING TRAINING
Summary of changes 2018 Coding Manuals: SEER and STORE 2018 KCR 2018 SPRING TRAINING Extent of Disease and Summary Stage Extent of Disease data items are now required by SEER Summary Stage 2018 is a revised
More informationEvolution of CoC within ACoS. American College of Surgeons Commission on Cancer Current Activities and Future Initiatives November 5,2005
American College of Surgeons Commission on Cancer Current Activities and Future Initiatives November 5,25 FREDERICK L. GREENE, MD Chair, Commission on Cancer Evolution of CoC within ACoS Two plans proposed
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationDr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013
Dr Ewan Hutchison UK Civil Aviation Authority ICAO European Regional Civil Aviation Medicine Seminar/Workshop București 11-15 November 2013 Types of Cancer Recertification after treatment Certification
More informationAneurin Bevan University Health Board Breast Cancer and Pregnancy Guideline
Breast Cancer and Pregnancy Guideline N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed versions of the document. The Intranet should be referred
More informationRequired Documents for 2018 Survey Application Record
Standard or ER ER1: Facility Accreditation ER2: Cancer Authority ER3: Cancer Conference Policy ER4: Oncology Nursing Leadership ER5: Cancer Registry Policy and Procedure ER6: Diagnostic Imaging Services
More informationUpdates on management of the axilla in breast cancer the surgical point of view
Updates on management of the axilla in breast cancer the surgical point of view Edwige Bourstyn Centre des maladies du sein Hôpital Saint Louis Paris Sentinel lymph node biopsy (SLNB) is the standard of
More informationNCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer. Project Overview Ronald C. Chen, MD MPH
NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer Project Overview Ronald C. Chen, MD MPH Introductions Principal Investigator: Ronald C. Chen, MD MPH ACS Staff: Eileen Tonner,
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationNUMERATOR: Reports that include the pt category, the pn category and the histologic grade
Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective
More informationQ&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
More informationFLORIDA CANCER DATA SYSTEM
National Cancer Survivors Month FLORIDA CANCER DATA SYSTEM SEER s Training Website: http://training.seer.cancer.gov/module_staging_cancer/unit01_sec01_staging_defined.html STAGING DEFINED The concept of
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationQ&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012
Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q: Will sticky notes be transferrable from the previous electronic version of CS to the updated version? A: It is our
More informationCERVIX MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve
More informationNUMERATOR: Reports that include the pt category, the pn category and the histologic grade
Measure #99 (NQF 0391): Breast Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationSTAGING, BIOPSY AND NATURAL HISTORY OF TUMORS SCOTT D WEINER MD
STAGING, BIOPSY AND NATURAL HISTORY OF TUMORS SCOTT D WEINER MD WHAT DO YOU DO WHEN THIS SHOWS UP IN YOUR OFFICE? besides panicking KEY PRINCIPLE!!! Reactive zone is the edema, neovascularity and inflammation
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationSTAGE CATEGORY DEFINITIONS
CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX Tis Tis (DCIS) Tis (LCIS) Tis (Paget s) T1 T1mi T1a T1b T1c a b c
More informationMelanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective
Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective Giorgos C. Karakousis, M.D. Associate Professor of Surgery Hospital of the University of Pennsylvania Disclosures
More informationDecember 2002 Monthly Memo
FLORIDA CANCER DATA SYSTEM December 2002 Monthly Memo CODING COMPLEX MORPHOLOGIC DIAGNOSES CODING COMPLEX BREAST HISTOLOGIES Apply these guidelines in priority order. Use the first guideline that applies
More informationPalliative Care in Patients with Brain Tumors: How to maintain hope and quality of life, even when treatments fail
Tobias Walbert MD PhD MPH Assistant Professor Neurology Wayne State University Henry Ford Hospital Detroit twalber1@hfhs.org Palliative Care in Patients with Brain Tumors: How to maintain hope and quality
More informationBringing the Fight to Cancer Annual Report
Bringing the Fight to Cancer. Annual Report Quality Study Improve process for breast biopsy patients to receive results of pathology reports Background A team from the Baylor Scott & White Medical Center
More informationUnderstanding Your Pathology Report
Understanding Your Pathology Report Because every person s breast cancer is unique, it s important to understand the underlying biology of your tumor to personalize your treatment plan. Your physicians
More informationCancer Registry Abstracting FLORIDA CANCER DATA SYSTEM
Cancer Registry 1 Learning Objectives 2 Integrate previously learned principles of cancer identification (anatomy, casefinding, site and histology identification principles, staging principles, and treatment
More information